Physician profile
Christopher L Hamill
NPI 1164495446
$1,218,586.35
in general payments reported to CMS, 2019-2025
19 companies · $429K in 2025
The $429K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $43K · 2021: $11K · 2022: $151K · 2023: $227K · 2024: $335K · 2025: $429K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $879K · Consulting Fee: $92K · Travel and Lodging: $17K · Food and Beverage: $3,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $878,868.64 |
| Consulting Fee | $91,590.44 |
| Travel and Lodging | $17,175.61 |
| Food and Beverage | $3,402.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,215,794.48 | 2019-2025 | Identiti, Other - Miscellaneous, Osseoscrew |
| Smaio Sa | $1,142.74 | 2022 | |
| Globus Medical, INC. | $575.22 | 2019 | |
| Relievant Medsystems, INC. | $196.79 | 2021 | |
| Stryker Corporation | $161.82 | 2019-2021 | |
| Cerapedics INC. | $142.20 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Abyrx, INC | $126.72 | 2019 | |
| Medtronic USA, INC. | $116.54 | 2019 | |
| Avanos Medical | $60.25 | 2020-2021 | |
| Axogen | $48.95 | 2023 | Avance Nerve Graft |
| Smith+Nephew, INC. | $37.94 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $32.31 | 2019-2022 | |
| Spineology INC. | $32.18 | 2021 | |
| Ebi, LLC | $30.74 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Abbott Laboratories | $22.38 | 2025 | Axium |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $21.15 | 2025 | Celleraterx |
| 7d Surgical INC. | $17.53 | 2020 | |
| Orthofix Medical, INC. | $13.49 | 2020 | |
| Pacira Therapeutics, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hamill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.